Literature DB >> 9574823

Characterization of the binding of MSH-B, HB-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes.

H B Schiöth1, R Muceniece, J E Wikberg.   

Abstract

We determined the binding affinities of the MSH analogues MSH-B, HP-228 and 153N-6 and of the enkephalin analogue GHRP-6 on a single eukaryotic cell line transiently expressing the human MC1, MC3, MC4 and MC5 receptors. Moreover, we tested the binding and cAMP response of MSH-B in comparison with alpha-MSH on murine B16 melanoma cells. Our results indicate that MSH-B has a potency similar to that of alpha-MSH and that these two peptides induce similar cAMP responses in murine B16 melanoma cells. HP-228 has its highest affinity for the MC1 receptor. For the other receptors, it has slightly higher affinity for the MC5 receptor than for the MC3 and MC4 receptors. 153N-6 was found to be selective for the MC1 receptor. GHRP-6 was found to bind to the MC1 and the MC5 receptors despite its low structural homology with alpha-MSH. [D-Lys3]GHRP-6 bound to all the four MC receptors with similar affinities. The structurally related Met-enkephalin and the functionally related GHRH, as well as LHRH and somatostatin-14 did not bind to these MC receptors. The low affinity of the GH-releasing/enkephalin peptides may indicate that they do not interact with the MC receptors at pharmacologically relevant concentrations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9574823     DOI: 10.1016/s0143-4179(97)90002-0

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  7 in total

1.  Mechanism related to reduction of intraocular pressure by melanocortins in rabbits.

Authors:  N Naveh; A Kaplan-Messas; J Marshall
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Ghrelin inhibits visceral afferent activation of catecholamine neurons in the solitary tract nucleus.

Authors:  Ran Ji Cui; Xiaojun Li; Suzanne M Appleyard
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

3.  Is there altered sensitivity to ghrelin-receptor ligands in leptin-deficient mice?: importance of satiety state and time of day.

Authors:  Beate C Finger; Harriët Schellekens; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2011-03-05       Impact factor: 4.530

4.  Diet-induced obesity blunts the behavioural effects of ghrelin: studies in a mouse-progressive ratio task.

Authors:  Beate C Finger; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2011-09-03       Impact factor: 4.530

5.  Melanocortin receptors, melanotropic peptides and penile erection.

Authors:  Stephen H King; Alexander V Mayorov; Preeti Balse-Srinivasan; Victor J Hruby; Todd W Vanderah; Hunter Wessells
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

6.  The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging.

Authors:  Masato Kobayashi; Toshitaka Kato; Kohshin Washiyama; Masaaki Ihara; Asuka Mizutani; Kodai Nishi; Leo G Flores; Ryuichi Nishii; Keiichi Kawai
Journal:  PLoS One       Date:  2019-03-22       Impact factor: 3.240

7.  Actions of Agonists and Antagonists of the ghrelin/GHS-R Pathway on GH Secretion, Appetite, and cFos Activity.

Authors:  Rim Hassouna; Alexandra Labarthe; Philippe Zizzari; Catherine Videau; Michael Culler; Jacques Epelbaum; Virginie Tolle
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-18       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.